Phase I study of replication-competent adenovirus-mediated double suicide gene therapy for local recurrence of prostate cancer after definitive radiation therapy

被引：0
|
作者：
Freytag, SO
Kim, JH
Khil, M
Nafziger, D
Menon, M
Peabody, J
Stricker, H
Deperalta-Venturina, M
Pegg, J
Aguilar-Cordova, E
机构：
[1] Henry Ford Hlth Syst, Detroit, MI USA
[2] Harvard Gene Therapy Initiat, Cambridge, MA USA
来源：
CANCER GENE THERAPY | 2000年 / 7卷 / 12期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
O59
引用
收藏
页码：S18 / S18
页数：1
相关论文
共 50 条
  • [1] Phase I study of replication-competent adenovirus-mediated double suicide gene therapy for the treatment of locally recurrent prostate cancer
    Freytag, SO
    Khil, M
    Stricker, H
    Peabody, J
    Menon, M
    DePeralta-Venturina, M
    Nafziger, D
    Pegg, J
    Paielli, D
    Brown, S
    Barton, K
    Lu, M
    Aguilar-Cordova, E
    Kim, JH
    [J]. CANCER RESEARCH, 2002, 62 (17) : 4968 - 4976
  • [2] Phase I trial of replication-competent adenovirus-mediated suicide gene therapy combined with IMRT for prostate cancer
    Freytag, Svend O.
    Movsas, Benjamin
    Aref, Ibrahim
    Stricker, Hans
    Peabody, James
    Pegg, Jan
    Zhang, Yingshu
    Barton, Kenneth N.
    Brown, Stephen L.
    Lu, Mei
    Savera, Adnan
    Kim, Jae Ho
    [J]. MOLECULAR THERAPY, 2007, 15 (05) : 1016 - 1023
  • [3] Replication-competent adenovirus-mediated suicide gene therapy with radiation in a preclinical model of pancreatic cancer
    Freytag, Svend O.
    Barton, Kenneth N.
    Brown, Stephen L.
    Narra, Vinod
    Zhang, Yingshu
    Tyson, Don
    Nall, Colleen
    Lu, Mei
    Ajlouni, Munther
    Movsas, Benjamin
    Kim, Jae Ho
    [J]. MOLECULAR THERAPY, 2007, 15 (09) : 1600 - 1606
  • [4] Efficacy and toxicity of replication-competent adenovirus-mediated double suicide gene therapy in combination with radiation therapy in an orthotopic mouse prostate cancer model
    Freytag, SO
    Paielli, D
    Wing, M
    Rogulski, K
    Brown, S
    Kolozsvary, A
    Seely, J
    Barton, K
    Dragovic, A
    Kim, JH
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 54 (03): : 873 - 885
  • [5] Phase I study of replication-competent adenovirus-mediated double suicide gene therapy in combination with three-dimensional conformal radiation therapy for the treatment of locally aggressive prostate cancer
    Freytag, SO
    Stricker, H
    Pegg, J
    Paielli, D
    Xia, S
    Brown, S
    Kim, JH
    [J]. MOLECULAR THERAPY, 2003, 7 (05) : S316 - S316
  • [6] Clinical trials of replication-competent adenovirus-mediated suicide gene therapy
    Barton, Kenneth N.
    Freytag, Svend O.
    Kim, Jae Ho
    [J]. JOURNAL OF GENE MEDICINE, 2007, 9 (06): : 525 - 525
  • [7] Toxicity, and efficacy of replication-competent adenovirus-mediated suicide gene therapy with radiation in a preclinical model of glioma
    Siddiqui, F.
    Barton, K.
    Peng, H.
    Zhang, H.
    Nelson, K. K.
    Mikkelsen, T.
    Brown, S.
    Movsas, B.
    Freytag, S. O.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S164 - S164
  • [8] Five-year follow-up of trial of replication-competent adenovirus-mediated suicide gene therapy for treatment of prostate cancer
    Freytag, Svend O.
    Stricker, Hans
    Peabody, James
    Pegg, Jan
    Paielli, Dell
    Movsas, Benjamin
    Barton, Kenneth N.
    Brown, Stephen L.
    Lu, Mei
    Kim, Jae Ho
    [J]. MOLECULAR THERAPY, 2007, 15 (03) : 636 - 642
  • [9] Adaptive seamless design for an efficacy trial of replication-competent adenovirus-mediated suicide gene therapy and radiation in newly-diagnosed prostate cancer (ReCAP Trial)
    Lu, Mei
    Freytag, Svend O.
    Stricker, Hans
    Kim, Jae Ho
    Barton, Kenneth
    Movsas, Benjamin
    [J]. CONTEMPORARY CLINICAL TRIALS, 2011, 32 (03) : 453 - 460
  • [10] Phase I study of replication-competent adenovirus-mediated double-suicide gene therapy in combination with conventional-dose three-dimensional conformal radiation therapy for the treatment of newly diagnosed, intermediate- to high-risk prostate cancer
    Freytag, SO
    Stricker, H
    Pegg, J
    Paielli, D
    Pradhan, DG
    Peabody, J
    DePeralta-Venturina, M
    Xia, XQ
    Brown, S
    Lu, M
    Kim, JH
    [J]. CANCER RESEARCH, 2003, 63 (21) : 7497 - 7506
12345